Juraklinik Scheßlitz
Hospital
Location:
Scheßlitz,
Germany (DE)
CRISPR-Cas9 screening reveals G2E3 as a novel ubiquitin-linked factor controlling autophagosome-lysosome fusion and cancer cell progression (2025)
Gong Y, Leon M, Mo H, Pengpaeng P, Yang H, Lu Y, Yin Z, et al.
Journal article
CRISPR/Cas9 Screening Highlights PFKFB3 Gene as a Major Contributor to 5-Fluorouracil Resistance in Esophageal Cancer (2025)
Xuefeng F, Yang H, Xu P, Zhang S, Britzen-Laurent N, Bao L, Grützmann R, et al.
Journal article